Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

Description

The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.

Conditions

Psoriasis, Psoriatic Arthritis, Psoriatic Conditions, Cardiovascular Diseases

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.

Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis: Translating Guidelines of Care to Better Outcomes for Patients With Psoriatic Disease

Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

Condition
Psoriasis
Intervention / Treatment

-

Contacts and Locations

Fort Smith

Johnson Dermatology, Fort Smith, Arkansas, United States, 72916

Columbus

Dawes Fretzin Clinical Research, Columbus, Indiana, United States, 47201

Indianapolis

Dawes Fretzin Clinical Research, Indianapolis, Indiana, United States, 46250

Northville

MiSkinCenter, Northville, Michigan, United States, 48167

Brooklyn

SUNY Downstate, Brooklyn, New York, United States, 11203

Bensalem

City Dermatology, Bensalem, Pennsylvania, United States, 19020

Philadelphia

University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Salt Lake City

University of Utah, Salt Lake City, Utah, United States, 84112

Charlottesville

University of Virginia, Charlottesville, Virginia, United States, 22903

Bellevue

Bellevue Dermatology Clinic, Bellevue, Washington, United States, 98004

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Willing and able to provide informed consent
  • 2. Male or female aged 40-75
  • 3. Being seen by a dermatology provider in routine care for the primary encounter diagnosis of psoriasis
  • 1. Currently taking a prescription lipid lowering medication
  • 2. Pregnant or planning pregnancy in the next 6 months
  • 3. Has a known history of cardiovascular disease (MI, Stroke, coronary artery, cerebrovascular, or peripheral vascular disease)

Ages Eligible for Study

40 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pennsylvania,

Study Record Dates

2025-10